Introduction

Transcranial magnetic stimulation (TMS) is a non-invasive and painless technique which was introduced by Barker et al. in 1985.
It works by creating a very large transient current which passes through the coil, produces a magnetic field and induces electrical current in other conductors (e.g. brain, spinal roots or nerves). TMS can be applied for understanding the physiology and the excitability of the motor cortex. [1] [2] [3] [4] [5] It has been used in different epileptic syndromes to investigate the localization of epileptic foci or speech function, changes of the cortical excitability or effects of the antiepileptic therapy (AT). [1] [2] [3] Former studies have shown that epileptogenesis is consisted of both excitatory and inhibitory mechanisms and TMS can be used for evaluating both excitatory and inhibitory effects on motor cortex. 2, 5, [26] [27] [28] [29] [30] [31] Motor threshold (MT) refers to the lowest stimulus intensity needed to generate the response in the target muscle and anatomically may reflect the density of network targeting the corticomotor neurons and physiologically may indicate the level of corticospinal system excitability. 2, 5, 6, 18, 27, 30, 32, 33 Besides exhibiting a motor evoked potential, a period of EMG suppression known as silent period (SP) occurs after single-pulse TMS during voluntary contraction. 2, 5, 6, 27, 32 Although the spinal and direct spinal inhibitory mechanisms are involved in the early and intermediate part of SP, the late part of SP is thought to be related to intracortical inhibitory mechanisms in primary motor cortex, leading to a failure of corticospinal drive. 2, 3, 5, 6, 27, 32, 34, 35 It has been suggested that using a single stimulus, (GABA) B -ergic intracortical circuits contribute to the generation of transcranially evoked SP, however, short interval intracortical inhibition (SICI) is mediated by (GABA) A -ergic intracortical circuits using paired stimuli. This opinion was supported by pharmacologic studies using GABA agonists such as benzodiazepines, baclofen, tiagabin, vigabatrin, zolpidem. 5, 17, 19, 23, 27, 32, 36, 37 Central motor conduction time (CMCT)
is an estimation of the conduction time in central motor pathways from motor cortex to the spinal motor neurons. 5, 6 CMCT duration
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consists of the period from the excitation of cortical neurons to the motor neurons conducted via the corticospinal/corticobulbar tracts. 5 Juvenile myoclonic epilepsy (JME) is one of the generalized idiopathic epileptic syndromes with complex inheritance pattern. [38] [39] [40] It is characterized by irregular myoclonic jerks of the shoulders and arms upon waking without any disturbance of consciousness, typical absence or generalized tonic clonic seizures. 25, [38] [39] [40] [41] [42] Typical EEG findings of JME are bilateral synchronous, 4-6 Hz spike/multiple spike and slow waves complexes. [38] [39] [40] [41] Different types of idiopathic epileptic syndromes were found in relatives of JME patients. [38] [39] [40] In some earlier reports, EEG abnormalities were demonstrated in siblings of JME patients. 38, 40, 42 In our previous study, we found EEG and somatosensory evoked potential (SEP) abnormalities not only in JME patients but also in their asymptomatic siblings. 40 In the literature, some TMS studies in epileptic patients had controversial results. Moreover, there were no TMS studies which were performed in asymptomatic siblings of epileptic patients. In this study, we mainly aimed to evaluate motor cortical excitability changes in JME patients and their asymptomatic siblings using single-pulse TMS (spTMS). The second aim of this study was to assess the safety of spTMS in this population.
Materials and methods
Subjects
There were three groups in this study. The first group consisted of 21 patients with JME (10F, 11 M; mean age AESD: 23.9 AE 3.4; range: 17-31) gathered from our epilepsy outpatient clinic. The second group consisted of their 21 asymptomatic siblings (12F, 9 M; mean age AESD: 22.8 AE 5.0; range: 13-33). They were all compared to 20 healthy controls (10F, 10 M; mean age AESD: 23.6 AE 5.7; range: 13-33). JME diagnosis was established according to clinical history and EEG findings. All of JME patients were receiving antiepileptic therapy and their seizures were well controlled. Patients who had generalized tonic clonic seizures in the last one year were excluded. None of the controls or asymptomatic siblings was taking any drugs which effect on central nervous system excitability such as sedatives, hypnotics, anticonvulsants or beta-blockers. All participants had normal neurological examination before and after the study. In all JME patients, CT and/or MR imagings were normal. The duration of the disease was 120 AE 47.6 months (mean AE SD; range: 36-228 months). First seizure type was myoclonic in 13 patients, generalized tonic clonic in 6 patients and absence in 2 patients. All of the patients had myoclonic jerks, except one patient (95.2%). Nine patients (42.9%) had absence, 17 patients (81%) experienced at least one generalized tonic clonic seizure throughout the disease duration. All of the patients were treated chronically with antiepileptic drugs (AED): Nineteen (90.5%) with valproic acid (VPA), one (4.8%) with VPA and lamotrigine (LTG) and one (4.8%) with VPA, LTG and Phenobarbital (PB). VPA dosage varied from 500 mg to 1500 mg, LTG dosage was 50 mg and PB dosage was 100 mg. The dosages of all antiepileptic drugs (AED) were within the therapeutic range at the last clinical admission.
The study was reviewed and approved by a local ethical committee. A written, informed consent form was collected from all subjects who were participated in the study.
Experimental procedures and recordings
Initially, standard EEG recordings including hyperventilation and photic stimulation were performed with a Medelec1118 device. In order to evaluate any effect of TMS study on EEG, a second EEG recording in each participant was done within the first hour after TMS.
During TMS studies, subjects were sitting on a comfortable armchair in a quiet, semi-darkened room. Hand dominancy was confirmed by the Edinburgh Handedness Test. 43 Motor evoked potential (MEP) responses were recorded from dominant hand abductor digiti minimi (ADM) muscle with Ag/AgCl cup electrodes. The active electrode was placed on the muscle belly and the reference over the fifth metacarpophalangeal joint. Initially, the ulnar nerve was stimulated at the dominant wrist using electrical stimulator and the amplitude of resulting compound muscle action potential (CMAP) was measured. Single-pulse magnetic stimulation was performed using a 135 mm circular coil connected to Magstim200 stimulator over the vertex. If left hemisphere was dominant, the direction of the current in the coil was anticlockwise and if right hemisphere was dominant the direction of the current in the coil was clockwise. MEP responses were recorded by Medelec Sapphire 4ME device. While the subjects were resting, motor threshold (RMT) was determined. Audio-visual feedback was given to the subjects in order to maintain complete electrical muscle silence. RMT was defined as the stimulus intensity at which a peak-to-peak MEP amplitude of 50 mV was obtained in at least 5 of 10 consecutive trials. During active muscle contraction, using 120% of the RMT as stimulus intensity, the shortest onset latency and the highest amplitude of 7 consecutive MEPs were obtained and latency and amplitude were measured. In order to avoid possible variability of MEP amplitudes, MEP amplitude/CMAP amplitude ratio (MEP/ CMAP) was calculated. Cervical roots were stimulated over the spinous process of the 7th cervical vertebra at maximal stimulator output when the subject was in a sitting position with a slight degree of neck flexion. Central motor conduction time (CMCT) was calculated by subtracting the latency of cervical response from the latency of cortical MEP response.
During CSP studies, subjects were held slight contraction of approximately 30% maximum voluntary contraction of contralateral ADM muscle. Audio-visual feedback was given to maintain the correct level activity. Stimulus intensity was maximal output of magnetic stimulator. 5 consecutive stimuli were delivered. The duration of CSP was measured from the end of the MEP until the reappearance of EMG activity and the shortest CSP value was selected for evaluation.
Statistics
Statistical analysis was performed using SPSS for Windows program. Sex and EEG results were compared to Chi-square test. Kappa test was used for comparing EEG results before and after TMS. The MEP results of three groups were compared to analysis of variance (ANOVA) tests with post hoc Bonferroni and Dunnet tests. A p value of <0.05 was considered to be statistically significant.
Results
The demographic data and clinical characteristics of the study are described in Table 1 . There were no significant differences between sex and the mean age of study groups (p = 0.814; F = 0.292, p = 0.748 respectively).
Before TMS examinations, six JME patients and one asymptomatic sibling had 4-6 Hz spike/polyspike and wave paroxysms (SPSWP). Three JME patients and 6 asymptomatic siblings had 6-7 Hz theta activity mixed with normal activity. This activity was defined as intermittent generalized slowing (IGS). After TMS examinations, we found 4-6 Hz spike/polyspike and wave paroxysms in 5 JME patients and one asymptomatic sibling; and we found IGS in 3 JME patients and 6 asymptomatic siblings ( Table 2 ). One of 6 JME patients with SPSWP changed into IGS and one of JME patients with IGS changed into normal after TMS examinations. Other patients' EEGs were the same before and after TMS. There were no significant differences between the first and second EEG recordings (K = 0.84) No seizures were recorded during or after the TMS study.
ANOVA analysis revealed significant differences of RMT values, CMCT and CSP durations between the three groups (F = 50.3; p < 0.001; F = 4.26; p = 0.019; F = 3.39; p = 0.04; respectively) RMT values of JME patients were found to be higher than those of AS and controls (p < 0.001, p < 0.001; respectively). On the other hand, we did not find any significant differences between AS and controls (p = 0.951). There were no differences between cortical MEP amplitude and MEP/CMAP ratio in the three groups (F = 0.43 p = 0.652; F = 1.64 p = 0.203; respectively). CMCT duration was shorter in JME patients than AS (p = 0.021). However, there were no significant differences between normal controls and in both JME patients and AS (p = 0.073, p = 0.727). CSP duration was found to be longer in JME patients as compared to the control group (p = 0.037). In AS, CSP duration was also found to be longer than controls but this difference was not considered to be statistically significant (p = 0.071) ( Table 3 ).
Discussion
Our results showed that RMT was higher, CSP was longer and CMCT was shorter in JME patients. In the literature, several TMS studies yielded different results. Although in some of these studies MT and CSP duration were not found to be different than normals; in some of them higher or lower MT and longer or shorter CSP duration were reported in epileptic patients compared to normals. These differences have been proposed to be related to the type of epilepsy, antiepileptic drug (AED) intake and also to methodology (using circular vs 8 shaped coil, different stimulus intensity etc. documented that both RMT and AMT were higher in untreated patients who experienced first generalized tonic clonic seizure (GTCS) in the previous 48 h than normals and after 2-4 weeks MT was not found different from normals. They proposed that these results could indicate protective mechanisms against the spread or recurrence of seizure. 15 In untreated focal epileptic patients, RMT
was not significantly different from normals in two studies, but in another study MT was found lower than normals. 26, 28, 30 However, in treated focal epileptic patients, RMT and/or AMT was higher than normal controls. 8, 20, 29 Manganotti et al. did not observe any significant differences in both RMT and AMT, MEP amplitude and intracortical facilitation between JME patients and controls. But in these studies, three JME patients did not take any antiepileptic drugs and at the same time the dosage of AED was also low in most of JME patients. 41, 42 In our study, all JME patients were using AED in therapeutic levels and we also found that RMT was higher in JME patients than their AS and controls.
In our present study, we found longer CSP duration in JME patients than controls. The studies in ''treated'' patients with partial epilepsy had contradictory results. In two different studies by Cantello et Table 2 EEG results of three study groups before and after TMS.
Before TMS After TMS JME AS Controls JME AS Controls Normal  12  14  20  13  14  20 SPSWP: spike/polyspike and wave paroxysms. IGS: Intermittent generalized slowing. in ''treated'' patients with primary generalized epilepsies. 20 Moreover, in a group of ''untreated'' patients who were tested after their first GTCS, CSP was not different from normals. 15 In a heterogeneous series of patients with generalized and partial seizure, prolongation of CSP was found most prominent in epileptic patients with uncontrolled seizures under medication. 14 Manganotti et al. did not observe any significant differences of CSP durations between JME patients and controls but found less MEP inhibition with 1 to 4 ms interstimulus intervals using paired pulse TMS (ppTMS). 41 Our results showed CSP prolongation in JME patients and their AS by contrast with Manganotti et al.'s study. In the literature, except one study, CMCT changes in epileptic patients were not reported. Hufnagel et al. asserted higher MT intensities and prolonged peripheral latencies in medically intractable epileptic patients. They found lower MTs and shorter peripheral latencies after decreasing antiepileptic therapy. They also noticed that CMCT was significantly decreased in patients with high frequency of seizures and after reducing antiepileptic drugs. They proposed that central motor pathways were endogenously facilitated by epileptiform activity. 8 In consistence with this study, we also found shorter CMCT in JME patients than their AS. But there were no significant differences between JME patients and normals. We considered that these results should be interpreted with care and re-evaluated in further studies. Transcranial magnetic stimulation provided not only evaluation of motor cortical excitability but also the pharmacological effects of antiepileptic therapy. Most of the studies showed that antiepileptic drugs (AEDs) which act by voltage-gated sodium channels such as phenytoin (PHT), carbamezepine (CBZ), valproate (VPA) and lamotrigine (LTG) increased MT in epileptic patients and in normal subjects after loading dose. 2, 5, 12, 18, 21, 27 In contrast, AEDs or other drugs enhancing GABA mediated inhibitory neurotransmission, such as lorazepam (LZP), diazepam (DZP), vigabatrin (VGB), gabapentin (GBP), baclofen (BAC) had no effect on MT. 2, 5, 12, 27, 36 On the other hand, PHT and LTG had no effect on CSP, whereas CBZ, LZP, GBP, BAC increased CSP duration and DZP produced a dose-dependent decreasing of CSP duration. 2, 5, 27 Our results showed higher MT and prolonged CSP in JME patients than controls. These findings might be attributed to drug effect. All of our patients were treated by VPA, one of them was also taking LTG and another patient was also using LTG and PB. Although VPA and LTG inhibit voltage-gated sodium channels; VPA also enhances GABA-mediated inhibitory neurotransmission. 2, 5, 22, 27 Reutens et al. reported that untreated IGE patients had lower MT than controls, however, after VPA therapy, MT significantly increased in IGE patients. They proposed that cortical excitability increased in IGE patients and reduced by following AED treatment. 2, 11 In contrast, Ziemann et al. observed that VPA had no effect on MT and CSP; LTG increased MT and did not change CSP duration. They suggested that this might be related to a low loading dose or delayed antiepileptic effect of VPA. 2 In our study, increased RMT may be referred to VPA effects. As reported by Ziemann et al., both VPA and LTG had no effect on CSP duration and prolongation of CSP in JME patients might reflect impairment of supraspinal and/or intracortical inhibitory mechanism instead of drug effect. Although there are concerns about the fact that TMS may induce seizures or kindling a seizure focus, some former studies showed that single-pulse TMS stimulation was safe in normal subjects and even in epileptic patients. [1] [2] [3] 6, 10, 13, 20, 27, 44, 45, 47 In some early studies, authors observed focal seizures triggered by TMS in epileptic patients. 44, 46 Hufnagel et al. found the probability of inducing seizure with spTMS to be lower than 5% in epileptic patients and this probability increased with low serum antiepileptic drug level, recently experienced spontaneous seizure, continuous epileptic activity on EEG before TMS and application of TMS on epileptic focus. 1, 47 Cantello et al. also declared that single and paired TMS did not cause seizure or EEG changes in cryptogenic localization-related epileptic patients. 13 Tataroglu et al. reported no clinical seizures just after TMS in their epileptic patients. They observed those patients for four weeks and did not find any significant differences between seizure frequency before and after TMS. 20 Schrader et al. reviewed published data and tried to determine seizure risk associated with single-and paired TMS in epileptic patients. They observed that medically intractable patients and low AED serum level increased the probability of inducing a seizure. 47 In our study, although six of JME patients and one asymptomatic sibling had 4-6 Hz spike/polyspike and wave paroxysms on EEG examination before TMS; we also did not notice any seizures in our study groups. After TMS examinations, one of our JME patients who had paroxysms on first EEG examination, paroxysms changed into IGS and another JME patient who had IGS before TMS, EEG examination was found to be normal. Our results are consistent with the literature findings which report TMS as a safe electrophysiological tool for investigating of motor cortex excitability in epileptic patients.
In conclusion, our results showed that RMT was higher in JME patients and CSP was longer in JME patients and their AS. Although high MT might be due to drug effect, the prolongation of CSP duration might reflect impairment of supraspinal and/or intracortical inhibitory mechanism. To eliminate the drug effect, further studies are needed in newly diagnosed JME patients without medication and large series of their asymptomatic siblings.
